Stay updated on Benralizumab in Hypereosinophilic Syndrome Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in Hypereosinophilic Syndrome Clinical Trial page.

Latest updates to the Benralizumab in Hypereosinophilic Syndrome Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2. No changes to study details, eligibility criteria, or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision: v3.4.1 released, replacing v3.4.0; no core content or study details are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page revision label updated from v3.3.3 to v3.3.4, with no changes to trial content or details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedLocations section was added with Maryland as a location, and the page revision was updated to v3.3.3. The Maryland Locations subsection and the HHS Vulnerability Disclosure link were removed, and the previous revision v3.3.2 was deleted.SummaryDifference0.2%

- Check91 days agoChange DetectedPublication notes were updated to indicate that PubMed automatically fills the list; the revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check99 days agoChange DetectedNotice about lapse in government funding and related operating status details was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Benralizumab in Hypereosinophilic Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in Hypereosinophilic Syndrome Clinical Trial page.